ZYLOX-TONBRDG.MED.TECH.H1
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. The company offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and in… Read more
Market Cap & Net Worth: ZYLOX-TONBRDG.MED.TECH.H1 (818)
ZYLOX-TONBRDG.MED.TECH.H1 (F:818) has a market capitalization of $770.59 Million (€750.72 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #11097 globally and #1190 in its home market, demonstrating a -4.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ZYLOX-TONBRDG.MED.TECH.H1's stock price €2.34 by its total outstanding shares 320819113 (320.82 Million).
ZYLOX-TONBRDG.MED.TECH.H1 Market Cap History: 2021 to 2026
ZYLOX-TONBRDG.MED.TECH.H1's market capitalization history from 2021 to 2026. Data shows change from $843.04 Million to $770.59 Million (-17.50% CAGR).
ZYLOX-TONBRDG.MED.TECH.H1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ZYLOX-TONBRDG.MED.TECH.H1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 818 by Market Capitalization
Companies near ZYLOX-TONBRDG.MED.TECH.H1 in the global market cap rankings as of March 19, 2026.
Key companies related to ZYLOX-TONBRDG.MED.TECH.H1 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
ZYLOX-TONBRDG.MED.TECH.H1 Historical Marketcap From 2021 to 2026
Between 2021 and today, ZYLOX-TONBRDG.MED.TECH.H1's market cap moved from $843.04 Million to $ 770.59 Million, with a yearly change of -17.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €770.59 Million | -0.85% |
| 2025 | €777.18 Million | +81.54% |
| 2024 | €428.11 Million | -5.11% |
| 2023 | €451.16 Million | -6.80% |
| 2022 | €484.09 Million | -42.58% |
| 2021 | €843.04 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ZYLOX-TONBRDG.MED.TECH.H1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $770.59 Million USD |
| MoneyControl | $770.59 Million USD |
| MarketWatch | $770.59 Million USD |
| marketcap.company | $770.59 Million USD |
| Reuters | $770.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.